Achyut Healthcare Fair Value
Achyut Healthcare (ACHYUT) average fair value is ₹19.72 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹6.84 (+188.3%), fair value range ₹1.99–₹42.59. Read ACHYUT dividend growth for the complete payout history and dividend yield track record.
Fair Value Analysis Export
ACHYUT Fair Value vs Current Price — Valuation Summary
ACHYUT average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Achyut Healthcare screener.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
ACHYUT Fair Value Analysis — Data Sources & Coverage
Achyut Healthcare financial data sources, valuation methods applied and sector benchmarks used. Browse ACHYUT complete financial statements for revenue, profit, balance sheet and cash flow data.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
ACHYUT vs Healthcare Sector Peers — P/E, P/B & Market Cap
Achyut Healthcare P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Aurobindo Pharma | AUROPHARMA | 25.88 | 2.53 | ₹96,652 |
| Sat Kartar Life | SATKARTAR | 13.37 | 3.34 | ₹226 |
| Emcure Pharmaceuticals | EMCURE | 36.8 | 7.52 | ₹37,799 |
| Syngene International | SYNGENE | 69.95 | 3.2 | ₹15,307 |
| Divis Laboratories | DIVISLAB | 85.36 | 14.9 | ₹247,470 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.